ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
Go back to ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older| ADMA Biologics Inc Com (NASDAQ: ADMA) | Delayed: 8.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.57 | 52 Week High | $9.65 | |||
| Open | $8.57 | 52 Week Low | $4.15 | |||
| Day High | $8.57 | P/E | N/A | |||
| Day Low | $8.57 | EPS | $-0.01 | |||
| Volume | 195 | |||||
